| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $2.03M | $3.94M | $2.28M | $1.53M | $640.60K |
| R&D | – | – | – | – | – |
| SG&A | $1.15M | $1.91M | $1.69M | $1.35M | $595.60K |
| Operating Income | – | – | – | – | -$640.60K |
| Interest Expense | – | – | $19.40K | $0.00 | – |
| Tax Expense | $6.37K | $91.28K | $861.42K | $630.07K | $0.00 |
| Net Income | -$2.34M | -$2.70M | $2.47M | $12.85M | $11.64M |
| EPS (basic) | – | – | – | – | – |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – |